This congress reaffirmed the collaboration between the two countries in the research and treatment of neurodegenerative diseases such as Alzheimer's, a condition with a higher incidence in aging societies like those of Spain and Portugal, and with a profound economic and social impact.

The ERC Starting Grant is one of Europe’s most prestigious and competitive research awards, designed to support promising early-career researchers who have the potential to become leaders in their fields. Ianuş will receive €2M over the next five years to develop her research project at King’s College London, where she recently joined as a Lecturer in Healthcare Engineering.

Here are some recurrent unproven claims:

How do we learn to make sense of our environment? Over time, our brain builds a hierarchy of knowledge, with higher-order concepts linked to the lower-order features that comprise them. For instance, we learn that cabinets contain drawers and that Dalmatian dogs have black-and-white patches, and not vice versa. This interconnected framework shapes our expectations and perception of the world, allowing us to identify what we see based on context and experience.

Co-organised by Fundación CIEN, Fundación Reina Sofía, and the Champalimaud Foundation, this scientific congress aims to bring advances in research in the fight against Alzheimer's and other neurodegenerative diseases to the public, and above all, to raise awareness to advance the search for global solutions and responses due to their social consequences.

Experts from two international nuclear medicine societies (EANM and SNMMI) have joined those from important societies of various other medical specialities involved in the care of breast cancer patients – including oncology, surgery, radio-oncology and breast imaging – to draw up a set of recommendations, based on scientific evidence, on the correct utilisation, in breast cancer, of a medical imaging exam. The exam in question has been used for several years and involves radioactive substances, in this case a glucose analogue called fluorodeoxyglucose (FDG).

THIS CALL IS NOW CLOSED 

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a 2 Postdocs to join our team at the Champalimaud Research Program. 

The selected candidate will:

The position

Now, Megan Carey from the Champalimaud Foundation (CF), Mónica Sousa from the Instituto de Investigação e Inovação em Saúde (i3S), Ricardo Henriques from the Instituto Gulbenkian de Ciência (IGC), and Rui Oliveira from IGC and the Instituto Universitário de Ciências Psicológicas Sociais e da Vida (ISPA), become EMBO Mem

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research

Venue

Seminar room

Abstract

To overcome the complexities of cancer and pave a path towards a cure, the McManus Lab is developing innovative approaches that consider both the genetic drivers of the disease and its interactions within the cellular environment. Join Dr. McManus to explore new technologies and methods to combat this multifaceted complex human disease.